- Home
- ITIC vs LAB Comparison
ITIC vs LAB Comparison
Compare ITIC & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITIC
- LAB
- Stock Information
- Founded
- ITIC 1972
- LAB 1999
- Country
- ITIC United States
- LAB United States
- Employees
- ITIC N/A
- LAB N/A
- Industry
- ITIC Specialty Insurers
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- ITIC Finance
- LAB Industrials
- Exchange
- ITIC Nasdaq
- LAB Nasdaq
- Market Cap
- ITIC 440.1M
- LAB 372.1M
- IPO Year
- ITIC N/A
- LAB 2011
- Fundamental
- Price
- ITIC $206.95
- LAB $1.22
- Analyst Decision
- ITIC
- LAB Buy
- Analyst Count
- ITIC 0
- LAB 2
- Target Price
- ITIC N/A
- LAB $2.50
- AVG Volume (30 Days)
- ITIC 78.0K
- LAB 2.3M
- Earning Date
- ITIC 08-05-2025
- LAB 07-30-2025
- Dividend Yield
- ITIC 7.73%
- LAB N/A
- EPS Growth
- ITIC 18.56
- LAB N/A
- EPS
- ITIC 15.69
- LAB N/A
- Revenue
- ITIC $261,197,999.00
- LAB $169,687,000.00
- Revenue This Year
- ITIC N/A
- LAB N/A
- Revenue Next Year
- ITIC N/A
- LAB $12.18
- P/E Ratio
- ITIC $13.38
- LAB N/A
- Revenue Growth
- ITIC 15.27
- LAB 33.86
- 52 Week Low
- ITIC $173.29
- LAB $0.92
- 52 Week High
- ITIC $290.40
- LAB $2.41
- Technical
- Relative Strength Index (RSI)
- ITIC 43.39
- LAB 60.66
- Support Level
- ITIC $204.58
- LAB $1.17
- Resistance Level
- ITIC $211.04
- LAB $1.31
- Average True Range (ATR)
- ITIC 5.09
- LAB 0.09
- MACD
- ITIC 1.63
- LAB 0.02
- Stochastic Oscillator
- ITIC 74.52
- LAB 39.83
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.